Skip to main content
High RiskFDAfda-F-2315-2014OTHER

Lindberg B-Complex, 50mg, 60 capsules (UPC 092865236601), 120 capsules (UPC 092865236120), 240 capsules (UPC 092865236243).

Category
Units Affected
667
Recall Date
July 8, 2014
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2315-2014.

Nutrition Express is recalling Lindberg B-Complex and Fitness Multi 1 vitamins because the amount of folic acid in the products was found to be higher than the label claim.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2315-2014.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Nutrition Express Corporation or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2315-2014.

Nutrition Express Corporation

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Nutrition Express Corporation Recall FAQ

Nutrition Express Corporation is the subject of a food safety report: Lindberg B-Complex, 50mg, 60 capsules (UPC 092865236601), 120 capsules (UPC 092865236120), 240 capsules (UPC 092865236243).. The notice was published on July 8, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 667 units are potentially affected.